Pediatric Nephrotic Syndrome
Conditions
Interventions
Control group:General treatment + hormone therapy regimen + proprietary Chinese medicine regimen
Observation group:General treatment + hormone therapy regimen + Dang Gui Shao Yao san Regimen
Sponsors
Heilongjiang Academy of Traditional Chinese Medicine (Heilongjiang Provincial Hospital of Traditional Chinese Medicine)
Eligibility
Sex/Gender
All
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1.Meets the diagnostic criteria for pediatric nephrotic syndrome and is in the initial onset; 2. Meets the indications for monotherapy with corticosteroids; 3.Aged between 3 to 14 years; 4.The child's family members or legal guardians are fully informed and voluntarily participate in this study, with a clear understanding of the study protocol.
Exclusion criteria
Exclusion criteria: 1.Children with secondary nephrotic syndrome caused by other diseases; 2.Those with severe dysfunction of other organs, such as heart failure, hepato-renal insufficiency, etc.; 3.Those with genetic diseases, congenital diseases, etc.; 4.Those with a history of allergy, contraindications, or refusal to the treatment involved in this study, making it impossible to proceed smoothly; 5. Those with mental disorders or cognitive impairments, unable to respond correctly to external stimuli; 6. Those who have participated in or are currently participating in other clinical trials within the past six months..
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary Protein;24-hour urinary protein quantification;Biochemical Series;Indicators related to vascular endothelial injury; | — |
Secondary
| Measure | Time frame |
|---|---|
| Other blood indicators; | — |
Countries
China
Contacts
Public ContactQin Man
Heilongjiang Academy of Traditional Chinese Medicine (Heilongjiang Provincial Hospital of Traditional Chinese Medicine)
Outcome results
None listed